Unknown PHASE2 INTERVENTIONAL 2-arm NCT01459640

Intra-Articular Autologous Bone Marrow Mesenchymal Stem Cells Transplantation to Treat Mild to Moderate Osteoarthritis

Phase 2 Study Assessing the Efficacy of Intra-Articular Autologous Mesenchymal Stem Cells in Patients With Mild to Moderate Osteoarthritis

Sponsor: Cytopeutics Pte. Ltd.

Conditions Osteoarthritis

Interventions Autologous bone marrow-derived mesenchymal stem cells Hyaluronic Acid

Updated 4 times since 2017 Last updated: Oct 24, 2011 Started: Mar 31, 2011 Primary completion: Mar 31, 2014 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01459640, this PHASE2 trial focuses on Osteoarthritis and remains ongoing. Sponsored by Cytopeutics Pte. Ltd., it has been updated 4 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE2

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cytopeutics Pte. Ltd.
National University of Malaysia

Data source: National University of Malaysia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kuala Lumpur, Malaysia